Evidence map›Paper›PMID 18573331›Full record

ArticleMicrobial pathogenesis2008

Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing.

Vishwanath Venketaraman, Albert K Lin, Amy Le, Scott C Kachlany, Nancy D Connell, Jeffrey B Kaplan

Abstract read
In one paragraph

Article in Microbial pathogenesis, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Pathogens (Basel, Switzerland) · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  7. The Role of Exopolysaccharides in Oral Biofilms.Journal of dental research · 2019
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vishwanath VenketaramanDepartment of Oral Biology, New Jersey Dental School, Newark, NJ 07103, USA.
Albert K Lin
Amy Le
Scott C Kachlany
Nancy D Connell
Jeffrey B Kaplan
Rutgers, The State University of New Jersey · USRutgers New Jersey Medical School

Funding

Leukotoxin production by A. actinomycetemcomitansR01DE016133 · NIDCR · UNIV OF MED/DENT OF NJ-NJ DENTAL SCHOOL · PI KACHLANY, SCOTT C · 2004 to 2009
$1.7M
Biofilm growth and detachment of an oral pathogenR01DE015124 · NIDCR · UNIV OF MED/DENT OF NJ-NJ DENTAL SCHOOL · PI KAPLAN, JEFFREY B · 2004 to 2007
$841k
NIDCR NIH HHS DE15124NIDCR NIH HHS DE16133NIDCR NIH HHS R01 DE015124NIDCR NIH HHS R01 DE016133
6 · The paper itself

Abstract

Two virulence factors produced by the periodontopathogen Aggregatibacter actinomycetemcomitans are leukotoxin, a secreted lipoprotein that kills human polymorphonuclear leukocytes and macrophages, and poly-N-acetylglucosamine (PGA), a surface polysaccharide that mediates intercellular adhesion, biofilm formation and detergent resistance. In this study we examined the roles of leukotoxin and PGA in protecting A. actinomycetemcomitans cells from killing by the human macrophage cell line THP-1. Monolayers of THP-1 cells were infected with single-cell suspensions of a wild-type A. actinomycetemcomitans strain, or of isogenic leukotoxin or PGA mutant strains. After 48h, viable bacteria were enumerated by dilution plating, macrophage morphology was evaluated microscopically, and macrophage viability was measured by a Trypan blue dye exclusion assay. The number of A. actinomycetemcomitans CFUs increased approximately twofold in wells infected with the wild-type strain, but decreased by approximately 70-90% in wells infected with the leukotoxin and PGA mutant strains. Infection with the wild-type or leukotoxin mutant strain caused a significant decrease in THP-1 cell viability, whereas infection with the PGA mutant strain did not result in any detectable changes in THP-1 viability. Pre-treatment of wild-type A. actinomycetemcomitans cells with the PGA-hydrolyzing enzyme dispersin B rendered them sensitive to killing by THP-1 cells. We concluded that both leukotoxin and PGA are necessary for evasion of macrophage killing by A. actinomycetemcomitans.

Indexed as

Actinobacillus InfectionsAggregatibacter actinomycetemcomitansAnimalsCell Line, TumorCell SurvivalExotoxinsHumansMacrophagesMicePolysaccharidesPolysaccharides, BacterialVirulence FactorsExotoxinsleukotoxinpoly-N-acetyllactosaminePolysaccharidesPolysaccharides, BacterialVirulence Factors

Identifiers

PMID18573331
PMCPMC2586082
OpenAlexW1970194716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.